Notably, significant correlations were observed between IL-6 levels and increased tryptophan metabolism.<h4>Conclusions</h4>This study underscores the prognostic value of specific proteins and metabolites in metastatic CCRCC, proposing potential biomarkers for patient stratification and treatment response prediction. Here, IL6 is linked to nonpapillary renal cell carcinoma.